Annals of Surgical Oncology

, Volume 24, Issue 3, pp 850–859

Attenuated RND1 Expression Confers Malignant Phenotype and Predicts Poor Prognosis in Hepatocellular Carcinoma

  • Hisateru Komatsu
  • Tomohiro Iguchi
  • Takaaki Masuda
  • Hidenari Hirata
  • Masami Ueda
  • Shinya Kidogami
  • Yushi Ogawa
  • Kuniaki Sato
  • Qingjiang Hu
  • Sho Nambara
  • Tomoko Saito
  • Shotaro Sakimura
  • Ryutaro Uchi
  • Shuhei Ito
  • Hidetoshi Eguchi
  • Keishi Sugimachi
  • Hidetoshi Eguchi
  • Yuichiro Doki
  • Masaki Mori
  • Koshi Mimori
Translational Research and Biomarkers

DOI: 10.1245/s10434-016-5573-9

Cite this article as:
Komatsu, H., Iguchi, T., Masuda, T. et al. Ann Surg Oncol (2017) 24: 850. doi:10.1245/s10434-016-5573-9
  • 216 Downloads

ABSTRACT

Background

The RND1 gene encodes a protein that belongs to the Rho GTPase family, which regulates various cellular functions. Depletion of RND1 expression activates the oncogenic Ras signaling pathway. In this study, we aimed to clarify the clinical significance of RND1 expression in predicting prognosis and to investigate its biological role in human hepatocellular carcinoma (HCC).

Methods

The association between RND1 expression and clinical outcomes in patients with HCC was analyzed in three independent cohorts: 120 cases resected in our hospital; 370 cases in The Cancer Genome Atlas (TCGA); and 242 cases in GSE14520. Gene set enrichment analysis (GSEA) was also conducted. Finally, knockdown experiments were performed using small interfering RNA (siRNA) in vitro.

Results

In all cohorts, RND1 expression was decreased as cancer progressed, and was affected by promoter methylation. In our HCC cases, the 5-year overall survival (OS) and recurrence-free survival of patients with low RND1 expression was significantly poorer than those of patients with high RND1 expression. TCGA and GSE14520 analyses provided similar results for OS. Multivariate analysis indicated that RND1 expression was an independent prognostic factor for OS in all three cohorts. Additionally, GSEA showed an inverse correlation between RND1 expression and the Ras signaling activity. In vitro, knockdown of RND1 expression resulted in significant increases in proliferation, invasion, and chemoresistance to cisplatin in HCC cells.

Conclusions

Reduced RND1 expression in HCC was associated with cancer progression, likely through regulation of the Ras signaling pathway, and may serve as a novel clinical biomarker for predicting prognosis in patients with HCC.

Supplementary material

10434_2016_5573_MOESM1_ESM.docx (19 kb)
Supplementary material 1 (DOCX 19 kb)
10434_2016_5573_MOESM2_ESM.docx (16 kb)
Supplementary material 2 (DOCX 17 kb)
10434_2016_5573_MOESM3_ESM.docx (17 kb)
Supplementary material 3 (DOCX 17 kb)
10434_2016_5573_MOESM4_ESM.docx (17 kb)
Supplementary material 4 (DOCX 18 kb)
10434_2016_5573_MOESM5_ESM.docx (17 kb)
Supplementary material 5 (DOCX 17 kb)
10434_2016_5573_MOESM6_ESM.docx (19 kb)
Supplementary material 6 (DOCX 20 kb)
10434_2016_5573_MOESM7_ESM.tif (34.9 mb)
Supplementary material 7 (TIFF 35703 kb)
10434_2016_5573_MOESM8_ESM.tif (34.9 mb)
Supplementary material 8 (TIFF 35703 kb)
10434_2016_5573_MOESM9_ESM.tif (2.2 mb)
Supplementary material 9 (TIFF 2264 kb)

Copyright information

© Society of Surgical Oncology 2016

Authors and Affiliations

  • Hisateru Komatsu
    • 1
    • 2
  • Tomohiro Iguchi
    • 1
  • Takaaki Masuda
    • 1
  • Hidenari Hirata
    • 1
  • Masami Ueda
    • 1
    • 2
  • Shinya Kidogami
    • 1
    • 2
  • Yushi Ogawa
    • 1
  • Kuniaki Sato
    • 1
  • Qingjiang Hu
    • 1
  • Sho Nambara
    • 1
  • Tomoko Saito
    • 1
  • Shotaro Sakimura
    • 1
  • Ryutaro Uchi
    • 1
  • Shuhei Ito
    • 1
  • Hidetoshi Eguchi
    • 1
  • Keishi Sugimachi
    • 1
  • Hidetoshi Eguchi
    • 2
  • Yuichiro Doki
    • 2
  • Masaki Mori
    • 2
  • Koshi Mimori
    • 1
  1. 1.Department of SurgeryKyushu University Beppu HospitalBeppuJapan
  2. 2.Department of Gastroenterological Surgery, Graduate School of MedicineOsaka UniversitySuitaJapan